A response to the commentary "Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms" by Loftis, J.M. on "Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms" by Udina, M., Moreno-España, J., Navinés, R., Gimenez, D., Langohr, K., Gratacòs, M., Capuron, L., de la Torre, R., Solà, R., Martin-Santos, R. http:\\dx.doi.org/10.1016/j.psyneuen.2013.03.007.

Autor: Udina M; Department of Psychiatry and Psychology, Hospital Clínic, IDIBAPS, CIBERSAM, Spain; Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Catalonia, Spain., Navinés R, Capuron L, Martín-Santos R
Jazyk: angličtina
Zdroj: Psychoneuroendocrinology [Psychoneuroendocrinology] 2013 Sep; Vol. 38 (9), pp. 1830-1. Date of Electronic Publication: 2013 Jun 28.
DOI: 10.1016/j.psyneuen.2013.05.019
Databáze: MEDLINE